GoKawiilLab tests find bodega 'retatrutide' vials contain no peptide, bacteria instead
CBS News had a vial labeled retatrutide, bought at a Brooklyn bodega, tested by University of Iowa bioorganic chemist Jason Galpin, who found it contained phenylacetic acid rather than any peptide compound. A separate analysis by Carl Ross, the university's Center for Biocatalysis and Bioprocessing development director, identified at least 13 bacterial colonies in the sample. A similar Wired investigation last month on bodega-bought peptides also found no actual peptides, only an unidentifiable chemical mixture.
GoKawiil's interpretation of the reporting above, not reported fact.
These findings suggest gray market peptide products sold outside pharmacies may pose real infection and contamination risks rather than simply being ineffective knockoffs. Ross's comment that injecting bacteria under the skin 'could multiply' implies a potential public health concern if such products spread through informal retail channels like bodegas. The repeated lab findings across two separate investigations may point to a broader pattern in the unregulated peptide trade rather than an isolated incident.
- A bodega-bought vial labeled retatrutide was found to contain phenylacetic acid, not an actual peptide.
- Testing identified at least 13 bacterial colonies in the sample, raising infection risks from injection.
- A separate Wired investigation similarly found no real peptides in bodega-sourced products, only unidentified chemicals.
Source: futurism.com — Joe Wilkins, 2026-10-24
Published there as: “Someone Ran a Chemical Analysis of Bodega Retatrutide and Dear Lord”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.